Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 8 | 2023 | 73 | 3.790 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2021 | 176 | 2.610 |
Why?
|
| Immunotoxins | 3 | 2023 | 11 | 1.250 |
Why?
|
| MicroRNAs | 4 | 2017 | 386 | 1.130 |
Why?
|
| Interferon Type I | 1 | 2023 | 17 | 0.960 |
Why?
|
| Apoptosis | 6 | 2015 | 1317 | 0.780 |
Why?
|
| Benzofurans | 2 | 2010 | 19 | 0.730 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 30 | 0.610 |
Why?
|
| Vitamin E | 2 | 2008 | 56 | 0.580 |
Why?
|
| Mice, Nude | 6 | 2017 | 323 | 0.530 |
Why?
|
| Replicon | 1 | 2014 | 6 | 0.500 |
Why?
|
| Viral Structural Proteins | 1 | 2014 | 16 | 0.500 |
Why?
|
| Dengue Vaccines | 1 | 2014 | 13 | 0.500 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 2128 | 0.500 |
Why?
|
| Mice | 11 | 2023 | 5668 | 0.490 |
Why?
|
| Salvia miltiorrhiza | 2 | 2010 | 5 | 0.470 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2010 | 21 | 0.470 |
Why?
|
| Dengue | 1 | 2014 | 93 | 0.440 |
Why?
|
| Cyclooxygenase 2 | 2 | 2011 | 92 | 0.440 |
Why?
|
| Genetic Testing | 1 | 2011 | 71 | 0.380 |
Why?
|
| Prostate-Specific Antigen | 1 | 2011 | 95 | 0.370 |
Why?
|
| Animals | 14 | 2023 | 14307 | 0.370 |
Why?
|
| Pyrazoles | 1 | 2010 | 80 | 0.360 |
Why?
|
| Sulfonamides | 1 | 2010 | 75 | 0.360 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 178 | 0.330 |
Why?
|
| Ceramides | 1 | 2008 | 41 | 0.320 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 600 | 0.300 |
Why?
|
| Cell Proliferation | 5 | 2015 | 1149 | 0.300 |
Why?
|
| Humans | 19 | 2024 | 34853 | 0.290 |
Why?
|
| Cheek | 1 | 2005 | 14 | 0.280 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 794 | 0.270 |
Why?
|
| Mouth Neoplasms | 1 | 2005 | 70 | 0.260 |
Why?
|
| Transfection | 2 | 2017 | 496 | 0.250 |
Why?
|
| Congenital Hypothyroidism | 1 | 2024 | 3 | 0.250 |
Why?
|
| Cricetinae | 3 | 2020 | 217 | 0.230 |
Why?
|
| Thyroid Neoplasms | 1 | 2024 | 35 | 0.230 |
Why?
|
| Mice, Inbred BALB C | 3 | 2017 | 649 | 0.230 |
Why?
|
| Quinolines | 2 | 2020 | 60 | 0.220 |
Why?
|
| Signal Transduction | 2 | 2023 | 1802 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2015 | 242 | 0.190 |
Why?
|
| Vertebrates | 1 | 2020 | 29 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2021 | 122 | 0.190 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2020 | 45 | 0.190 |
Why?
|
| Dinoprostone | 2 | 2010 | 57 | 0.180 |
Why?
|
| Doxorubicin | 2 | 2012 | 80 | 0.180 |
Why?
|
| Virus Replication | 1 | 2020 | 261 | 0.170 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 126 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 3 | 2011 | 480 | 0.160 |
Why?
|
| Male | 6 | 2017 | 18870 | 0.160 |
Why?
|
| Flow Cytometry | 3 | 2009 | 392 | 0.160 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 114 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2017 | 58 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2020 | 486 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2017 | 49 | 0.150 |
Why?
|
| Tocopherols | 2 | 2008 | 62 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 105 | 0.140 |
Why?
|
| Gene Dosage | 1 | 2015 | 74 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 53 | 0.140 |
Why?
|
| Neoplasms | 2 | 2015 | 1033 | 0.130 |
Why?
|
| Cell Line | 2 | 2020 | 1289 | 0.130 |
Why?
|
| HIV-1 | 1 | 2020 | 678 | 0.130 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2015 | 72 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 61 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 756 | 0.120 |
Why?
|
| Virus Assembly | 1 | 2014 | 38 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 286 | 0.120 |
Why?
|
| Capsid Proteins | 1 | 2014 | 60 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 145 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2014 | 156 | 0.120 |
Why?
|
| Drug Synergism | 2 | 2012 | 171 | 0.120 |
Why?
|
| Dengue Virus | 1 | 2014 | 84 | 0.120 |
Why?
|
| Colony-Forming Units Assay | 2 | 2011 | 12 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2015 | 226 | 0.110 |
Why?
|
| Loperamide | 1 | 2012 | 1 | 0.110 |
Why?
|
| Gene Expression | 1 | 2015 | 639 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2012 | 41 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1124 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 26 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1490 | 0.100 |
Why?
|
| Prostatic Hyperplasia | 1 | 2011 | 33 | 0.100 |
Why?
|
| Prostatectomy | 1 | 2011 | 56 | 0.100 |
Why?
|
| Caspase 3 | 2 | 2008 | 194 | 0.090 |
Why?
|
| Cell Survival | 2 | 2015 | 818 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 424 | 0.090 |
Why?
|
| Cell Division | 1 | 2010 | 296 | 0.090 |
Why?
|
| Mouth Mucosa | 1 | 2009 | 33 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2009 | 20 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 87 | 0.090 |
Why?
|
| Keratinocytes | 1 | 2009 | 65 | 0.090 |
Why?
|
| Caspases | 1 | 2009 | 132 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 107 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 1426 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1152 | 0.080 |
Why?
|
| Caspase 9 | 1 | 2008 | 27 | 0.080 |
Why?
|
| Survival Rate | 1 | 2009 | 310 | 0.080 |
Why?
|
| Transferrin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Infrared Rays | 1 | 2008 | 18 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2008 | 72 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 1007 | 0.080 |
Why?
|
| Mutation | 2 | 2024 | 1023 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2009 | 834 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 137 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 468 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 781 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2009 | 1442 | 0.070 |
Why?
|
| Nicotine | 1 | 2007 | 238 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2024 | 32 | 0.060 |
Why?
|
| Female | 4 | 2015 | 19873 | 0.060 |
Why?
|
| District of Columbia | 1 | 2022 | 68 | 0.050 |
Why?
|
| Health Services | 1 | 2022 | 53 | 0.050 |
Why?
|
| Furin | 1 | 2020 | 5 | 0.050 |
Why?
|
| Vero Cells | 1 | 2020 | 90 | 0.050 |
Why?
|
| Isoquinolines | 1 | 2020 | 40 | 0.050 |
Why?
|
| Protein Phosphatase 1 | 1 | 2020 | 58 | 0.050 |
Why?
|
| Mass Screening | 1 | 2024 | 427 | 0.050 |
Why?
|
| Hela Cells | 1 | 2020 | 344 | 0.040 |
Why?
|
| Aged | 1 | 2011 | 6448 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2020 | 172 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2022 | 301 | 0.040 |
Why?
|
| Proteins | 1 | 2020 | 352 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 531 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 537 | 0.040 |
Why?
|
| Middle Aged | 1 | 2011 | 9642 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1300 | 0.040 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2015 | 9 | 0.040 |
Why?
|
| Diamines | 1 | 2015 | 7 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2015 | 20 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 27 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 195 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 485 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2015 | 35 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 173 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 284 | 0.030 |
Why?
|
| DNA | 1 | 2015 | 549 | 0.030 |
Why?
|
| Antidiarrheals | 1 | 2012 | 3 | 0.030 |
Why?
|
| United States | 1 | 2022 | 3894 | 0.030 |
Why?
|
| Rhodamine 123 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Drug Resistance, Multiple | 1 | 2012 | 26 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 638 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 105 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 67 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 209 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2012 | 351 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 309 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 12 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 25 | 0.020 |
Why?
|
| Exocytosis | 1 | 2008 | 45 | 0.020 |
Why?
|
| Fluorescence | 1 | 2008 | 117 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2007 | 31 | 0.020 |
Why?
|
| Endocytosis | 1 | 2008 | 104 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 45 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2007 | 45 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 136 | 0.020 |
Why?
|
| Smoking | 1 | 2007 | 903 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 3414 | 0.010 |
Why?
|